{"title":"NUCKS1 exacerbates hepatocellular carcinoma cell proliferation and metastasis via the upregulation of Cdc42.","authors":"Weiwang Fan, Yuchen Ma, Jiaming Wu, Xinchen Zhang","doi":"10.62347/IAMC6442","DOIUrl":null,"url":null,"abstract":"<p><p>Nuclear casein kinase and cyclin-dependent kinases substrate 1 (NUCKS1) is overexpressed in hepatocellular carcinoma (HCC), but its role and regulatory mechanism in the development and progression of HCC remains unknown. Here, we report that the RNA and protein levels of NUCKS1 were significantly increased in HCC tissues. The inhibition of NUCKS1 notably decreased the proliferation and migration of SNU449 and HepG2 cells. However, NUCKS1 overexpression exacerbated cell growth and migration. Additionally, NUCKS1 depletion reduced the sphere formation efficiency and inhibited tumorigenesis in vivo. Mechanistically, depletion of NUCKS1 downregulated the expression of cell division control protein 42 (Cdc42), and NUCKS1 directly bound to the promoter of Cdc42 and transcriptionally upregulated Cdc42, which promoted the development and progression of HCC. Furthermore, the expression of NUCKS1 was positively associated with Cdc42 in HCC tissues. Collectively, our data indicate that the increasing expression of NUCKS1 plays an oncogenic role and promotes progression via transactivation of Cdc42 expression in HCC.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"15 3","pages":"1051-1065"},"PeriodicalIF":3.6000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11982718/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/IAMC6442","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Nuclear casein kinase and cyclin-dependent kinases substrate 1 (NUCKS1) is overexpressed in hepatocellular carcinoma (HCC), but its role and regulatory mechanism in the development and progression of HCC remains unknown. Here, we report that the RNA and protein levels of NUCKS1 were significantly increased in HCC tissues. The inhibition of NUCKS1 notably decreased the proliferation and migration of SNU449 and HepG2 cells. However, NUCKS1 overexpression exacerbated cell growth and migration. Additionally, NUCKS1 depletion reduced the sphere formation efficiency and inhibited tumorigenesis in vivo. Mechanistically, depletion of NUCKS1 downregulated the expression of cell division control protein 42 (Cdc42), and NUCKS1 directly bound to the promoter of Cdc42 and transcriptionally upregulated Cdc42, which promoted the development and progression of HCC. Furthermore, the expression of NUCKS1 was positively associated with Cdc42 in HCC tissues. Collectively, our data indicate that the increasing expression of NUCKS1 plays an oncogenic role and promotes progression via transactivation of Cdc42 expression in HCC.
期刊介绍:
The American Journal of Cancer Research (AJCR) (ISSN 2156-6976), is an independent open access, online only journal to facilitate rapid dissemination of novel discoveries in basic science and treatment of cancer. It was founded by a group of scientists for cancer research and clinical academic oncologists from around the world, who are devoted to the promotion and advancement of our understanding of the cancer and its treatment. The scope of AJCR is intended to encompass that of multi-disciplinary researchers from any scientific discipline where the primary focus of the research is to increase and integrate knowledge about etiology and molecular mechanisms of carcinogenesis with the ultimate aim of advancing the cure and prevention of this increasingly devastating disease. To achieve these aims AJCR will publish review articles, original articles and new techniques in cancer research and therapy. It will also publish hypothesis, case reports and letter to the editor. Unlike most other open access online journals, AJCR will keep most of the traditional features of paper print that we are all familiar with, such as continuous volume, issue numbers, as well as continuous page numbers to retain our comfortable familiarity towards an academic journal.